Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATGross ProfitLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Dna X (SONM) Receivables - Other (2020 - 2025)

Dna X's Receivables - Other history spans 6 years, with the latest figure at $9.8 million for Q3 2025.

  • Quarterly results put Receivables - Other at $9.8 million for Q3 2025, up 1428.11% from a year ago — trailing twelve months through Sep 2025 was $9.8 million (up 1428.11% YoY), and the annual figure for FY2024 was $181000.0, down 81.17%.
  • Receivables - Other for Q3 2025 was $9.8 million at Dna X, up from $7.0 million in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $9.8 million in Q3 2025 to a low of $181000.0 in Q4 2024.
  • The 5-year median for Receivables - Other is $1.4 million (2022), against an average of $2.4 million.
  • The sharpest move saw Receivables - Other tumbled 81.17% in 2024, then soared 1428.11% in 2025.
  • Year by year, Receivables - Other stood at $2.3 million in 2021, then rose by 0.62% to $2.3 million in 2022, then tumbled by 57.65% to $961000.0 in 2023, then tumbled by 81.17% to $181000.0 in 2024, then surged by 5337.02% to $9.8 million in 2025.
  • According to Business Quant data, Receivables - Other over the past three periods came in at $9.8 million, $7.0 million, and $181000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.